Skip to main content
. 2020 May 2;96(8):fiaa081. doi: 10.1093/femsec/fiaa081

Table 2.

AMR patterns of V. parahaemolyticus isolates (n = 594).

Antimicrobial resistance pattern No. of V. parahaemolyticus isolates (%)
  Oyster (n = 361) Estuarine water (n = 233) Total (n = 594)
1 ERY 76 (21.0) 54 (23.3) 130 (21.9)
2 SUl 13 (3.6) 8 (3.4) 21 (3.5)
3 TRI 29 (8.0) 12 (5.2) 41 (6.9)
4 AMP 2 (0.6) 7 (3.0) 9 (1.5)
5 STR 1 (0.3) 0 (0) 1 (0.2)
6 ERY-SUL 43 (11.9) 27 (11.6) 70 (12.0)
7 ERY-TRI 19 (5.3) 6 (2.6) 25 (4.2)
8 ERY-AMP 8 (2.2) 11 (4.7) 19 (3.2)
9 ERY-STR 1 (0.3) 0 (0) 1 (0.2)
10 SUL-TRI 12 (3.3) 16 (6.9) 28 (4.7)
11 SUL-AMP 7 (1.9) 2 (0.9) 9 (1.5)
12 TRI-AMP 3 (0.8) 1 (0.4) 4 (0.7)
13 TRI-STR 1 (0.3) 0 (0) 1 (0.2)
14 ERY-SUL-TRI 28 (7.8) 22 (9.4) 50 (8.4)
15 ERY-SUL-STR 2 (0.6) 0 (0) 2 (0.3)
16 ERY-SUL-AMP 10 (2.8) 1 (0.4) 11 (1.9)
17 ERY-TRI-AMP 2 (0.6) 1 (0.4) 3 (0.5)
18 SUL-TRI-AMP 1 (0.3) 3 (1.3) 4 (0.7)
19 ERY-SUL-TRI-AMP 4 (1.1) 3 (1.3) 7 (1.2)
20 ERY-SUL-TRI-TET 0 (0) 3 (1.3) 3 (0.5)
Total 262 (72.6) 177 (76.0) 439 (73.9)

ERY, erythromycin; SUL, sulfamethoxazole; TRI, trimethoprim; AMP, ampicillin; STR, streptomycin; TET, tetracycline.